The present study aims to clarify the effects of sex, age, body mass index (BMI), and puberty on transaminase serum levels in children and adolescents and to provide new age-and sex-related percentiles for alanine aminotransferase (ALT), aspartate aminotransferase (AST), and c-glutamyltransferase (GGT). Venous blood and anthropometric data were collected from 4,126 cases. Excluded were cases of participants with potential hepatotoxic medication, with evidence of potential illness at the time of blood sampling and non-normal BMI (BMI <10th or >90th). The resulting data (N 5 3,131 cases) were used for the calculations of ALT, AST, and GGT percentiles. Age-and sex-related reference intervals were established by using an LMS method of Cole-type method. Serum levels of transaminases follow age-specific patterns and relate to the onset of puberty. This observation is more pronounced in girls than in boys. ALT percentiles showed similar-shaped patterns in both sexes. Multivariate regression confirmed significant effects of puberty and BMI-SDS (b 5 2.21) on ALT. Surprisingly, AST serum levels were negatively influenced by age (b 5 21.42) and BMI-SDS (b 5 20.15). GGT percentiles revealed significant sexspecific differences, correlated positively with age (b 5 0.37) and showed significant association with BMI-SDS (b 5 1.16). Conclusion: Current reference values of ALT, AST, and GGT serum levels were calculated for children between 11 months and 16.0 years, using modern analytical and statistical methods. This study extends the current knowledge about transaminases by revealing influences of age, sex, BMI, and puberty on serum concentrations of all three parameters and has for these parameters one of the largest sample sizes published so far. (HEPATOLOGY 2017; 
T he high prevalence of obesity and nonalcoholic fatty liver disease (NAFLD) as well as the early onset of other liver diseases require the availability and accuracy of diagnostic instruments for detection of liver damage during early life. Transaminases are usually present in the blood at low levels and an increase in their concentrations may indicate damage of liver cells.
(1) Furthermore, hepatic enzyme serum concentrations are associated with obesity, insulin resistance (IR), and type 2 diabetes in adults. (2) The World Health Organization recommends in children the transformation of measurement values into standard deviation scores (SDSs) as the best way to assess their meaning in the context of age and sex for anthropometric parameters. This approach has been progressively applied and extended to other parameters. In the past 7 years, several approaches have been made to establish new reference intervals or thresholds for liver enzymes in children, (3) (4) (5) (6) (7) (8) (9) particularly for alanine aminotransferase (ALT). Schwimmer et al. (4) as well as Molleston et al. (10) were able to show that the upper limit of ALT used in children's hospitals varies widely and is set too high to detect chronic liver disease reliably. This could be attributed to the fact that many of the reference values in current use have been derived from small cohorts of healthy or hospitalized individuals or focus on a limited age range with arbitrary partitions. (5) Discrete age groups, however, do not adequately reflect the continuous changes during biological development and thus cannot always represent the exact extent and onset of age-dependent dynamics. Partition into discrete age groups for both males and females is commonly performed to describe the age and sex dependence of laboratory parameters. A continuous approach with age-and sex-related percentiles seems to be the appropriate method for laboratory analytes and will, therefore, be applied in this study. (9) Such an approach requires a large number of samples from healthy children and adolescents.
OBJECTIVES
We aim to provide new age-and sex-related percentiles for ALT, aspartate aminotransferase (AST), and c-glutamyltransferase (GGT) based on data from a large cohort of primarily healthy and normal weight children and adolescents between 11 months and 16.0 years of age (from the LIFE [Leipzig Research Centre for Civilization Diseases] Child cohort, a representative population-based cohort in Germany). (11, 12) These percentiles are a condition to better evaluate pathological liver enzyme serum levels in order to detect children at risk for chronic liver diseases. We aim to study potential effects of sex, age, body mass index (BMI; body mass index 5 body weight/(height 2 ) in kg/m 2 ) and puberty on transaminase serum levels during early life.
Materials and Methods
This article is structured according to the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) Statement checklist for cohort studies. (13) STUDY DESIGN, CLINICAL STUDY REGISTRATION, AND ETHNICAL REVIEW LIFE Child is a prospective, longitudinal, population-based cohort study with a life course approach to health and disease. The LIFE Child study has been designed to understand how and through which mechanisms and mediators (epi) genetic, metabolic, and environmental factors influence health and development in children and adolescents in modern society. (11, 12) The LIFE Child study was designed pursuant to the Declaration of Helsinki (14) and is registered under the clinical trial number NCT02550236. The ethical committee of the University of Leipzig (Leipzig, Germany; Reg. No. 264-10-19042010) had no objection.
SETTING
Informed and written consent was obtained from all participants and their parents. Data were pseudonymized according to German data protection law. The primary program carried out at each study center visit includes clinical history, clinical examination, blood collection, hair and urine samples, anthropometry, and different age-dependent questionnaires. (11, 12) In this study, we only included cases with complete data sets of ALT, AST, GGT, age, and BMI. Samples with too little sample material for analysis were excluded.
PARTICIPANTS
Children residing in Leipzig or neighboring municipalities between 11 months and 16.0 years were eligible for participation. The participants of this study are primarily healthy (no severe diseases like malignancies, syndromal diseases, or diabetes) children and adolescents. Thus, their data are well suited to calculation of reference values.
VARIABLES
ALT, AST, and GGT serum levels were determined in context of sex, age, pubertal stage, and BMI.
DATA SOURCES/MEASUREMENTS
At the beginning of every visit, all children participating in the LIFE Child study were asked to provide fasting, morning venous blood. The blood was collected by venipuncture (serum monovettes; Sarstedt AG&Co, N€ umbrecht, Germany). The analysis was done immediately in the Central Laboratory of the University Hospital Leipzig. ALT and AST (ultraviolet tests), GGT, and alkaline phosphatase (ALP; colorimetric tests) as well as high-sensitivity C-reactive protein (hs-CRP; latex-enhanced immunoturbidimetric test) were measured with cobas analyzer series (photometric measuring unit, c-module; Roche Diagnostics GmbH, Mannheim, Germany). Platelets were measured on the Sysmex XN-9000 automated hematology analyzer (Sysmex Europe, Norderstedt, Germany). Only CE in vitro diagnostic-certified laboratory tests approved for diagnostic use were applied, and all analytical procedures were performed according to the manufacturer's instruction. (11) Height was measured with the stadiometer ("Prof. Keller"; L€ angenmesstechnik GmbH Limbach, Limbach-Oberfrohna, Germany) with a measurement accuracy of 0.10 cm. Participants were weighed with the "Seca 701" scale (seca GmbH & Co. KG, Hamburg, Germany) which is accurate to 50 g. Pubertal stage was assessed according to Tanner stages (15, 16) by specially trained and regularly instructed investigators.
STUDY SIZE
A total of 4,662 complete cases of 2,471 individuals between the ages of 0 and 18 years from 1,819 families were available (LIFE Child cohort). To assure to work with a primarily healthy and normal weight cohort, we needed to carry out several steps of exclusion (Fig. 1 (17, 18) the reference population was restricted to children and adolescents with normal weight (BMI-SDS between the 10th and 90th percentile).
The resulting data (N 5 3,131 cases) were used for the calculations of ALT, AST, and GGT percentiles.
STATISTICAL ANALYSES
Percentile curves for ALT, AST, and GGT were estimated as functions of the covariate age stratified by sex using a LMS method of Cole (LMS)-type method (LMSP) implemented in the package, gamlss. (19) Assuming a Box-Cox Power Exponential distribution, the LMSP method of Cole (20) models four parameters (l, r, m, and s) as a function of age by using a log link. These may be interpreted as relating to location (median), scale (centile-based coefficient of variation), skewness (power transformation to symmetry), and kurtosis (degrees of freedom). (20) Estimation of parameters as continuous functions of age seems to be a more appropriate approach to reflect the physiological development of laboratory analytes. (9, 21) Because LIFE Child has a longitudinal study design and recruits families participated with more than one child, our sampled data contain multiple measurements per child as well as measurements of siblings. Therefore, percentile calculations had to follow an adapted approach. To maintain the independence of all measurements, but also consider all measurements for the calculation, we calculated each model 1,000 times on distinct subsamples of 600 independent values (one per family). The weighting was defined to maintain the same probability for each value to be chosen. (22) The mean estimated parameter (location, scale, shape, and kurtosis) built the basis for the calculation of the reference values. The process was carried out twice: After the first iteration, all measurement values were transformed into SDSs, and the exclusion criteria were applied as described above. After that, the process was repeated on the cleaned data set. Finally, percentile curves for the 3rd (P3), 10th (P10), 50th (P50), 90th (P90), and 97th (P97) centile were calculated. The 3rd and 97th percentiles were defined as lower and upper limit of the reference interval. To determine the strength of the relationship of the different parameters, a hierarchical linear regression analysis was performed. All regression analyses were carried out using multivariate linear mixed models with sex, age, BMI-SDS, and pubertal stage as predictors (Table 1) . By adding random effects on the intercept for the individual nested within its family, we accounted for possible correlations between measurements and therefore for multiple measurements per person/family. The Tanner stages (15, 16) were separated into three groups (Tanner stage 1, stages 2-4, and stage 5 reflecting prepubertal, pubertal, and postpubertal stages) to emphasize on puberty-specific changes in transaminases serum levels. Analyses were performed using the package, lme4 (23) (version 1.1.10), in R (version 3.2.3; R Foundation for Statistical Computing, Vienna, Austria), which accounts for multiple measurements. (24) Results
DESCRIPTION OF THE STUDY POPULATION
The reference population used to calculate percentiles is composed of 3,131 cases (53.1% male cases) from 1,746 individuals of 1,308 families. Excluded were cases of participants with potential hepatotoxic medication, potential illness at the time of measurement, and cases of children with underweight, overweight, or obesity. Underweight, overweight, and obesity were defined by using the 10th, 90th, and 97th percentile of the BMI-SDS as cutoffs. (25) For regression analyses, we used the LIFE Child study population including cases from underweight (7.6%), normal weight (75.9%), overweight (7.4%), and obese (9.1%) children and adolescents. Mean BMI-SDS of this population was 0.20 for girls and 0.13 for boys; this slightly elevated mean can be explained by the rising number of overweight and obese children, and especially adolescents, in Germany over the past decades. (26) Characteristics of both populations are represented as mean (6 SD) and median values in Supporting Table S2 .
PERCENTILES OF LIVER ENZYME SERUM LEVELS DERIVED FROM A PRIMARILY HEALTHY AND NORMAL WEIGHT PEDIATRIC COHORT
The smoothed percentile curves (Figs. 2-4) for ALT, AST, and GGT are presented for boys and girls.
The corresponding reference values are represented as P3, P10, P50 (median), P90, and P97 and tabulated the coefficient of variation (sigma), skewness (nu), and kurtosis (tau) in half-year age groups and separated for boys and girls (Supporting Tables S3-S5). ALT percentiles show a similar-shaped pattern in boys and girls and starting with a peak in infancy, followed by a drop of the median until the age of 4.0 in girls and 6.5 years in boys. After that decline, we found rising values, which resulted in an earlier ALT peak in girls (17.7 U/L between 7.5 and 9.5 years) and a later peak in boys (18.5 U/L at 11.5 years). During early adolescence, the median ALT serum concentrations fall continuously in boys and in girls. Whereas this decline was found in all depicted percentiles in girls, the 90th and 97th percentiles in boys remained stable, even slightly increased. Median ALT serum concentration varies between 14.0 and 20.3 U/L in girls and between 17.1 and 21.1 U/L in boys. The 97th percentile, which is commonly used as a cutoff, spans from 24.2 to 31.7 U/L in girls and from 29.9 to 38.0 U/L in boys. The range between the 3rd and the 97th percentile is more apparent in boys during preschool and adolescence and more pronounced in girls during puberty.
Both female and male AST percentiles follow a continuous downward trend with increasing age, which differs considerably from the patterns shown by ALT and GGT serum levels. Before the age of 11, no significant sex-specific differences can be found for P50, but after that age, AST serum concentrations more strongly decrease in girls. Boys present decreasing medium serum concentrations, whereas the female percentiles appear to reach a plateau at 23.1 U/L. The median spans from 23.1 to 46.1 U/L in girls and from 25.7 to 47.6 U/L in boys. The upper limit (97th percentile) ranges from 35.2 to 62.9 U/L in females and ALT, AST, and GGT are dependent variables in relation to sex, age, BMI-SDS, and pubertal stage (independent variables).
Only cases with complete data regarding modeling were included. All calculations were adjusted for sex, age, BMI-SDS, and pubertal stage. from 41.5 to 68.7 U/L in males. All female percentiles curves follow parallel courses, whereas enlarging ranges between P3 and P97 were apparent in boys, especially with the onset of puberty. The GGT pattern revealed sex-specific differences. Whereas there is a continuous increase of P50 in boys over the whole age span, girls' GGT serum levels rise until they reach a maximum of 12.0 U/L at the age of 9.5 years. After that peak, the serum concentrations slightly fall to reach a plateau of 11.0 U/L at 13.5 years. Median serum concentrations vary from 9.5 to 12.0 U/L in girls and from 9.4 to 14.8 U/L in boys. The upper limit (97th percentile) ranges from 14.5 to 18.1 U/L in girls and from 14.1 to 27.4 U/L in boys.
The parameter tables for each of the parameters are provided as part of an R package including convenient functions to transform measurement values into SDS values. It is openly available from CRAN (http:// CRAN.R-project.org/package5childsds). Practically, it would so either be possible to calculate the centile/ SDS of a patient's value and provide this in addition to the absolute levels (or the patient level could be plotted into the curves). This would even provide the opportunity to track the laboratory values longitudinally. Alternatively, the normal range could be given in agespecific reference intervals.
INFLUENCING FACTORS ON LIVER ENZYME SERUM LEVELS: EFFECTS OF AGE, SEX, PUBERTY, AND BMI
All cases between 11 months and 16 years (including all BMIs) with complete data regarding modeling were considered for the multivariate regression analysis. Regression analyses were performed twice with the raw and SDS values of the depended variables to account for age-and sex-specific effects. Detailed results are summarized in Table 1 .
INFLUENCE OF AGE
AST and GGT serum concentrations are significantly associated with age. Whereas AST serum levels significantly decrease with increasing age (b 5 21.4), GGT serum levels significantly rise with age (b 5 0.37). However, there is no significant effect of age on ALT serum levels found beyond the effect already conveyed by puberty.
INFLUENCE OF SEX
All three liver enzymes are significantly associated with sex. Boys present higher mean serum levels of ALT, AST, and GGT compared to girls. This effect is strongest for AST (b5 21.77), medium for ALT (b 5 21.65), and weakest for GGT (b 5 21.17).
INFLUENCE OF PUBERTY
Puberty has significant effects on all three investigated transaminases independently of age. During puberty (Tanner stage 2-4), children exhibit significantly higher ALT (b 5 6.29) and GGT (b 5 4.36) serum levels compared to prepubertal children (Tanner stage 1). These effects are stronger than the associations with age. In contrast, AST serum concentrations are negatively associated with puberty (b 5 21.28). Postpubertal adolescents (Tanner stage 5) revealed significantly lower transaminases serum levels compared to prepubertal children (b 5 220.67 for ALT, -20.97 for AST, and -11.83 for GGT). 
INFLUENCE OF BMI

ELEVATED ALT SERUM LEVELS ARE ASSOCIATED WITH A HIGHER PEDIATRIC NAFLD SCORE
Liver biopsy remains the gold standard for assessing NAFLD severity and staging of fibrosis; however, performing a liver biopsy for screening purpose is neither practical nor ethical and therefore cannot be part of a cohort study. For this reason, Alkhouri et al. (27) have developed a noninvasive test to identify children with advanced fibrosis (fibrosis score 3): The Pediatric NAFLD Fibrosis Score (PNFS), which was defined as: z 5 1.11(0.34*sqrt(ALT)) 1 0.002*ALP) -(1.1*log(-platelets)) -(0.02*GGT). This value was converted into a probability distribution. We applied the recommended cutoff of 8%, which would provide sensitivity and specificity values of 97% and 33% to detected children with advanced liver fibrosis (LF). (27) However, this new score was not validated in further studies.
We found that increasing liver enzyme SDS values are accompanied by a higher PNFS. This influence is higher than the mathematical influence of the respective term in the formula. In addition, Fig. 5 revealed that children with ALT serum concentrations above the 97th percentile present significantly higher (P < 0.001) PNFS values compared to children with lower ALT serum levels (<97th percentile). Furthermore, we found that 7.9% of the overweight/obese children show PNFS values above 8%. By looking at the group of children with overweight/obesity and ALT serum levels >97th percentile, this percentage even represents 39.5%. However, also, 29.0% of children with normal weight and elevated ALT serum concentrations (>97th percentile) present PNFS values above 8%, possibly indicating a high risk for advanced LF.
Discussion
Our study presented age-and sex-specific percentiles of ALT, AST, and GGT derived from the LIFE Child cohort in Germany, which consists of 3,131 cases of normal weight children and adolescents between 11 months and 16.0 years. This study presents percentiles for all three transaminases derived from normal weight children and adolescents, carried out within a standardized protocol of a cohort study and is one of the largest cohort studies on this topic. In the past 7 years, various studies have been conducted to examine ALT in children and adolescents, whereas far fewer have been performed for AST or GGT. Characteristics of studies that published reference intervals or percentiles for transaminases are available in Supporting Table S6 . The primary studies are KiGGS (8) (nationwide health survey in children and adolescents carried out by the Robert Koch Institute, Germany), Estey et al. (5) (results from the CALIPER [Canadian Laboratory Initiative in Pediatric Reference Intervals] cohort study, Canada), Zierk et al., (9) Schwimmer et al. (4) (SAFETY [Screening ALT For Elevation in Today's Youth] study, USA), England et al., (6) Poustchi et al., (3) and Dehghani et al.
COMPARISON OF OUR NEW PERCENTILES WITH PREVIOUS CUTOFFS AND REFERENCE INTERVALS
The aforementioned studies differ markedly regarding the country of origin, ethnical structure of the reference populations, age groups applied, inclusion and exclusion criteria, sample size, laboratory devices, statistical methods, and serum levels proposed as the cutoff. Whereas most of the studies used P95 as the upper limit, Zierk et al., (9) KiGGS, (8) and LIFE Child propose P97/P97.5 as a threshold. Only KiGGS (8) and England et al. (6) estimated percentiles; Zierk et al. (9) applied a mixture of healthy and pathological samples and a complex statistical approach to calculate percentiles. Dehghani et al. (7) presented reference values for three distinct age intervals. This explains substantial differences in the serum levels proposed as cut-off values.
The initial decrease in ALT has also been described by England et al., (6) and apart from the missing ALT peak in early puberty in boys, Zierk et al. (9) presented similar patterns for boys and girls. Their reference values are only slightly higher than our 97th percentile values, especially during infancy. Estey et al., (5) Schwimmer et al., (4) Poustchi et al., (3) and Dehghani et al. (7) published reference values that are markedly below ours. Looking at the trends shown by reference intervals of distinct age groups, we found noticeable changes during the onset of puberty. According to Siest et al., (28) the most commonly used cut-off values for ALT and AST in adults are 40 U/L (range, 30-50). Kim et al. (29) recently estimated male thresholds of 30 U/L for ALT and 31 U/L for AST to be the best cutoffs for prediction of liver disease. These cutoffs show good accord for our ALT P97, but are significantly below our AST upper limit. Our AST threshold exceeds 31 U/L throughout the observed age span. Apart from Kim et al., (29) only a few studies exist that examined AST. Estey et al. (5) and Zierk et al. (9) both found similar dynamics to our percentiles for boys and girls, whereas Dehghani et al. (7) presented increasing reference values over age for both sexes. The proposed cut-off values from Estey et al. (5) and Dehghani et al. (7) are below our 97th percentiles, but those published by Zierk et al. (9) are in good accord. GGT percentiles were published by KiGGS (8) in 2009 and by Zierk et al. (9) in 2015. Their percentiles correspond quite well with ours. The LIFE Child percentiles slightly exceed KiGGS' (8) serum levels during adolescence. Compared to Zierk et al. (9) our reference values are slightly higher in girls during adolescence.
Comparing all mentioned reference values, we found differences in the described trends, particularly during the onset of puberty. The previously published patterns showed varying changes during that period, such as dips or rises. However, variations have also been found within our percentiles. Most studies described sex-specific differences in serum level concentrations. (4, 6, 8, 9) In addition, we showed that sex disparity with regard to transaminases appears to increase with age. Boys exceed girls with their serum concentration regarding all three transaminases. Obviously, age and, more significantly, puberty influence the level of transaminases.
Differences as described above may be partly caused by an increasing liver size or rising muscle mass with age as well as changing fat-muscle distribution, especially during puberty. (30, 31) Interactions between sex hormones and metabolic processes (e.g., IR) may contribute to sex-and puberty-specific alterations. (32) (33) (34) 
POTENTIAL NAFLD IN OVERWEIGHT CHILDREN WITH ELEVATED ALT
NAFLD is the most common form of hepatic disease during childhood. (35) Its overall prevalence in children has reached approximately 10%, including up to 17% in teenagers and 40%-70% among obese children. (36) It appears twice as often in boys than in girls and has its onset mainly peripubertal. (35, 37) NAFLD encompasses a large spectrum of conditions ranging from simple hepatic steatosis, which is reversible, to steatohepatitis with or without fibrosis and to hepatic cirrhosis and its complications. (35) We found that 39% of the overweight/obese children with elevated ALT serum levels presented PNFS values above 8%, possibly indicating an increased risk for advanced LF. However, it is well known that new scoring systems need to be evaluated externally by further (comparing) studies. The PNFS is a new tool and its utility and transferability from one study cohort to another cohort need to be assessed, addressing also possible bias attributed to heterogeneity in pediatric NAFLD in different countries.
Early diagnosis and therapy are essential to prevent further progression. For that reason, it is important to have access to reliable reference values derived from primarily healthy and normal weight children, especially during critical phases like puberty.
STRENGTHS AND LIMITATIONS
The main strengths of our study are the composition and large sample size of the reference population, standardized assessment, and usage of statistical and laboratory methods. LIFE Child is one of the largest cohorts of primarily healthy and normal weight children and adolescents in Europe and therefore very well suited for the calculation of reference values. This study provides an openly available R package including convenient functions to transform measurement values into SDS values for ALT, AST, and GGT. Regarding limitations, others have already reported that the composition of the LIFE Child cohort differs from the general distribution in the city of Leipzig, especially regarding the social background of the participants. (38) Children from socially disadvantaged families were under-represented in the LIFE Child study, possibly because of a less-pronounced health awareness. (39) Because of the ethnic composition of the city of Leipzig and under-representation of nonwhites, this study does not describe the potential influence of ethnicity on transaminases. Therefore, the suitability and/or comparability of these reference values for other ethnicities needs to be investigated.
The usage of the PNFS scoring system is a further limitation of this study. This score has been developed recently, therefore its superior performance has not yet been confirmed by studies other than Alkhouri et al. (27) However, this noninvasive scoring system could be a useful screening tool to select children with NAFLD who are at risk for advanced disease to undergo further investigations and more-aggressive monitoring.
Current reference values of ALT, AST, and GGT serum concentrations from primarily healthy and normal weight children and adolescents between 11 months and 16.0 years were proposed. A methodological approach permitted a detailed description of age dependency. We found that age, sex, BMI, and puberty status influence the patterns of the three transaminases considered here and highlight the need for sex-and age-specific reference values. The utility of these current reference values in children and adolescents has to be evaluated by further studies. We hope that this study will contribute to daily practice in health care for children and adolescents.
